Min-Sung is a Managing Partner at Digital Health Ventures (DHV), a specialized Venture Capital fund based in Berlin. Min-Sung’s international investment experience ranges from early-stage, to late-stage. Min-Sung is passionate about opportunities in Digital Health and is both enthusiastic about the immense value creation potential through digital technologies as well as the resulting positive impact on society.
Since 2013, Min-Sung invested in successful Digital Health companies such as mySugr, NeuroNation, Mimi, Medbelle, hi.health and Amwell (IPO 2020). Before joining DHV as Managing Partner, Min-Sung was responsible for the Berlin office of Samsung Catalyst Fund and helped in creating AllianzX (USD 2.0 bn assets under management). Min-Sung studied Management and Business at Witten/Herdecke, Harvard, St. Gallen, and in Seoul.